IRIN examines HIV/AIDS response in Guinea-Bissau

IRIN reports on the HIV/AIDS response in Guinea-Bissau, writing, "One year after the Global Fund to Fight AIDS, Tuberculosis and Malaria reduced funding to the Guinea-Bissau government body in charge of coordinating HIV prevention and treatment activities, health centers outside the capital are facing medicine shortages, patients are not receiving the treatment they need, and the transport of patients to treatment centers has been cut." According to the news service, "The Global Fund stopped most of its funding to the Secretriado National de Luta Contra le Sida (SNLS), the government structure in charge of coordinating the HIV response, at the end of 2011, because of poor performance management and a lack of transparent fiduciary controls."

"The Global Fund continued to supply basic medicines and testing through their Voluntary Pooled Procurement facility, the official procurement body of the Global Fund, which buys and delivers medicines for countries unable to do so themselves, said David Te, director of care at SNLS," IRIN writes. "But SNLS, which is in charge of transporting medicines to clinics and hospitals across the country and overseeing medicine storage and stock-taking, has had no money to pay staff salaries for one year, and lacks finances for transport or even electricity," IRIN continues. According to the news service, "[t]he Fund told IRIN in a written statement that it is 'working with partners in the country to find alternative arrangements for program implementation,'" and "[i]t hopes to resume grant activities, financing essential prevention, treatment and care, once a sound fiduciary agent has been named" (12/12).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity